Zydus receives final USFDA approval to marketmedications for menopause and epilepsy.

Zydus has been given the go-ahead by the US Food and Drug Administration (USFDA) to market the
Estradiol Transdermal System USP. The firm stated at the time of this announcement that Estradiol
Transdermal System is approved to treat mild to moderately severe symptoms of menopause, including
sudden strong feelings of heat, hot flushes, and dryness of the vaginal mucosa in women.
Yesterday, December 1, the United States Food and Drug Administration (USFDA) officially authorised
Zydus Lifesciences Limited to distribute Topiramate extended-release capsules. Topiramate Extended-
Release pill is indicated to prevent and control seizures in people with epilepsy, according to the
business, which made this declaration. It may also be used to stop migraines from occurring.
Zydus Lifesciences Ltd. is a large-cap company that works in the pharmaceutical sector with a market
value of $41.515.55 Cr. In terms of pharmaceutical companies, Zydus Group comes in at number
four.The group’s formulation manufacturing facility in Ahmedabad, India, will be where both the drugs
would be produced.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close